| 000 | 01333 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513134256.0 | ||
| 264 | 0 | _c19980423 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a0161-8105 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMignot, E | |
| 245 | 0 | 0 |
_aHLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. _h[electronic resource] |
| 260 |
_bSleep _cNov 1997 |
||
| 300 |
_a1012-20 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBenzhydryl Compounds _xtherapeutic use |
| 650 | 0 | 4 |
_aCataplexy _xdrug therapy |
| 650 | 0 | 4 |
_aCentral Nervous System Stimulants _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHLA-DQ Antigens _ximmunology |
| 650 | 0 | 4 |
_aHaplotypes _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModafinil |
| 650 | 0 | 4 |
_aNarcolepsy _xcomplications |
| 650 | 0 | 4 | _aRacial Groups |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSleep, REM _xphysiology |
| 700 | 1 | _aHayduk, R | |
| 700 | 1 | _aBlack, J | |
| 700 | 1 | _aGrumet, F C | |
| 700 | 1 | _aGuilleminault, C | |
| 773 | 0 |
_tSleep _gvol. 20 _gno. 11 _gp. 1012-20 |
|
| 999 |
_c9425558 _d9425558 |
||